12-110913338-C-T
Variant summary
Our verdict is Likely benign. The variant received -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_000432.4(MYL2):c.275-14G>A variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_000432.4 intron
Scores
Clinical Significance
Conservation
Publications
- hypertrophic cardiomyopathyInheritance: AD Classification: DEFINITIVE Submitted by: ClinGen
- hypertrophic cardiomyopathy 10Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: ClinGen, G2P, PanelApp Australia, Labcorp Genetics (formerly Invitae)
- myopathy, myofibrillar, 12, infantile-onset, with cardiomyopathyInheritance: AR Classification: MODERATE Submitted by: Ambry Genetics
- congenital fiber-type disproportion myopathyInheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
- dilated cardiomyopathyInheritance: AD Classification: LIMITED Submitted by: ClinGen
- arrhythmogenic right ventricular cardiomyopathyInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
Genome browser will be placed here
ACMG classification
Our verdict: Likely_benign. The variant received -2 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt | 
|---|---|---|---|---|---|---|---|---|
| MYL2 | NM_000432.4 | c.275-14G>A | intron_variant | Intron 4 of 6 | ENST00000228841.15 | NP_000423.2 | ||
| MYL2 | NM_001406745.1 | c.233-14G>A | intron_variant | Intron 3 of 5 | NP_001393674.1 | |||
| MYL2 | NM_001406916.1 | c.218-14G>A | intron_variant | Intron 4 of 6 | NP_001393845.1 | 
Ensembl
Frequencies
GnomAD3 genomes  
GnomAD4 exome Cov.: 35 
GnomAD4 genome  
ClinVar
Submissions by phenotype
Hypertrophic cardiomyopathy    Uncertain:1 
This variant causes a G to A nucleotide substitution at the -14 position of intron 4 of the MYL2 gene. To our knowledge, functional studies have not been reported for this variant. This variant has not been reported in individuals affected with MYL2-related disorders in the literature. This variant has not been identified in the general population by the Genome Aggregation Database (gnomAD). The available evidence is insufficient to determine the role of this variant in disease conclusively. Therefore, this variant is classified as a Variant of Uncertain Significance. -
Computational scores
Source: 
Splicing
 Find out detailed SpliceAI scores and Pangolin per-transcript scores at